Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 26 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the effects of acute insulin-induced hypoglycemia on inflammation, endothelial dysfunction, and platelet activation in adults with and without type 1 diabetes. RESEARCH DESIGN AND METHODS: We studied 16 nondiabetic adults and 16 subjects with type 1 diabetes during euglycemia (blood glucose 4.5 mmol/l) and hypoglycemia (blood glucose 2.5 mmol/l). Markers of inflammation, thrombosis, and endothelial dysfunction (soluble P-selectin, interleukin-6, von Willebrand factor [vWF], tissue plasminogen activator [tPA], high-sensitivity C-reactive protein [hsCRP], and soluble CD40 ligand [sCD40L]) were measured; platelet-monocyte aggregation and CD40 expression on monocytes were determined using flow cytometry. RESULTS: In nondiabetic participants, platelet activation occurred after hypoglycemia, with increments in platelet-monocyte aggregation and P-selectin (P ≤ 0.02). Inflammation was triggered with CD40 expression increasing maximally at 24 h (3.13 ± 2.3% vs. 2.06 ± 1.0%) after hypoglycemia (P = 0.009). Both sCD40L and hsCRP (P = 0.02) increased with a nonsignificant rise in vWF and tPA, indicating a possible endothelial effect. A reduction in sCD40L, tPA, and P-selectin occurred during euglycemia (P = 0.03, P ≤ 0.006, and P = 0.006, respectively). In type 1 diabetes, both CD40 expression (5.54 ± 4.4% vs. 3.65 ± 1.8%; P = 0.006) and plasma sCD40L concentrations increased during hypoglycemia (peak 3.41 ± 3.2 vs. 2.85 ± 2.8 ng/ml; P = 0.03). Platelet-monocyte aggregation also increased significantly at 24 h after hypoglycemia (P = 0.03). A decline in vWF and P-selectin occurred during euglycemia (P ≤ 0.04). CONCLUSIONS: Acute hypoglycemia may provoke upregulation and release of vasoactive substances in adults with and without type 1 diabetes. This may be a putative mechanism for hypoglycemia-induced vascular injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Acute hypoglycemia is proinflammatory, increases platelet activation and decreases fibrinolysis, leading to a prothrombotic state (65,66).”
From Hypoglycemia (2018) · cites this paper as [65]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“While supported by anecdotal reports (3), the increase in cardiovascular mortality in people with type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (4) (and possibly in the Veterans Affairs Diabetes Trial [5]), in which intensive treatment had tripled the frequency of severe hypog…”
ResultWinearls, C., Pippard, M., Downing, M., Oliver, D., Reid, C., & Mary Cotes, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92192-6 · Cited by 1,401
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Self-citationAbumrad, N. N., Rabin, D., Diamond, M. P., & Lacy, W. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90074-3 · Cited by 567
CD40 Signaling and Plaque Instability
Schönbeck, U., & Libby, P. (2001) · Circulation Research · doi:10.1161/hh2401.101272 · Cited by 566 · cited 1×
“Monocyte CD40 expression also increased, suggesting promotion of the interaction of the CD40-CD40 ligand dyad (from the tumor necrosis factor receptor family), thus affecting another process in the pathway leading to atherosclerotic plaque rupture (19,20).”
BackgroundVascular disease and diabetes: Is hypoglycaemia an aggravating factor?
Wright, R. J., & Frier, B. M. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.865 · Cited by 336 · cited 1×
“While supported by anecdotal reports (3), the increase in cardiovascular mortality in people with type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (4) (and possibly in the Veterans Affairs Diabetes Trial [5]), in which intensive treatment had tripled the frequency of severe hypog…”
ResultSelf-citationProinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects
Razavi Nematollahi, L., Kitabchi, A. E., Stentz, F. B., Wan, J. Y., Larijani, B. A., Tehrani, M. M., Gozashti, M. H., Omidfar, K., & Taheri, E. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.018 · Cited by 210
Research works printed but not linked: 1
- Thompson, 1993, Endocrine changes during insulin-induced hypoglycaemia, 116
Cited by
Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Self-citationde Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 503
“soluble CD40 ligand concentration, greater platelet-monocyte aggregation (100), and increased circulation of plasminogen activator inhibitor, vascular endothelial growth factor, vascular adhesion molecules, interleukin-6, and markers of platelet aggregation (99).”
BackgroundPapachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 479
Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications
Frier, B. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.170 · Cited by 481
Self-citationde Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 433
Ceriello, A., Novials, A., Ortega, E., Canivell, S., La Sala, L., Pujadas, G., Esposito, K., Giugliano, D., & Genovese, S. (2013) · Diabetes Care · doi:10.2337/dc12-2469 · Cited by 204
“Evidence suggests that both hyperglycemia and hypoglycemia can induce endothelial dysfunction and inflammation, producing oxidative stress (3,4,7).”
BackgroundCerebral ischemic damage in diabetes: an inflammatory perspective
Shukla, V., Shakya, A. K., Perez-Pinzon, M. A., & Dave, K. R. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0774-5 · Cited by 200
“All these changes increase the risk of myocardial and cerebral ischemia [240].”
BackgroundFatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.045 · Cited by 173
The importance of hypoglycemia in diabetic patients
Shafiee, G., Mohajeri-Tehrani, M., Pajouhi, M., & Larijani, B. (2012) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-11-17 · Cited by 163
“Sympathoadrenal stimulation and release of counterregulatory hormones during acute hypoglycemia causes hemodynamic changes including white blood cell activation and inflammatory mediators and cytokines release [47,48].”
BackgroundHypoglycaemic episodes and risk of dementia in diabetes mellitus: 7‐year follow‐up study
Lin, C. ‐., & Sheu, W. H. ‐. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12000 · Cited by 149
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
on behalf of the DEVOTE Study Group, Pieber, T. R., Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pratley, R. E., Woo, V., Heller, S., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4422-0 · Cited by 148
Hypoglycemia in Type 2 Diabetes - More Common Than You Think: A Continuous Glucose Monitoring Study
Gehlaut, R. R., Dogbey, G. Y., Schwartz, F. L., Marling, C. R., & Shubrook, J. H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815581052 · Cited by 131
“Hypoglycemia-induced increases in blood pressure and heart rate, triggering of blood vessel constriction or acute thrombosis are probable explanations of these adverse events.(27,28) However, most studies on GV have been conducted in critical care settings and findings may not extend to T2DM patients in the outpatient…”
BackgroundHypoglycemia and Cardiovascular Risk: Is There a Major Link?
Hanefeld, M., Frier, B. M., & Pistrosch, F. (2016) · Diabetes Care · doi:10.2337/dcs15-3014 · Cited by 121
Self-citationKahal, H., Halama, A., Aburima, A. A., Bhagwat, A. M., Butler, A. E., Graumann, J., Suhre, K., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-61531-z · Cited by 122
Exercise-related hypoglycemia in diabetes mellitus
Younk, L. M., Mikeladze, M., Tate, D., & Davis, S. N. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.78 · Cited by 114
Yale, J.-F., Paty, B., & Senior, P. A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.010 · Cited by 105
We Can Change the Natural History of Type 2 Diabetes
Phillips, L. S., Ratner, R. E., Buse, J. B., & Kahn, S. E. (2014) · Diabetes Care · doi:10.2337/dc14-0817 · Cited by 103
“poglycemia could trigger acute cardiovascular events (20,21).”
Morales, J., & Schneider, D. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.004 · Cited by 128
Joy, N. G., Tate, D. B., Younk, L. M., & Davis, S. N. (2015) · Diabetes · doi:10.2337/db14-1729 · Cited by 99
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity
Ferrari, F., Moretti, A., & Villa, R. F. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.317959 · Cited by 126
“…are produced upon hypoglycemia, i.e. interleukin-6, tumor necrosis factor α, C-reactive protein, endothelin-1 and P-selectin (Galloway et al., 2000; Wright et al., 2010), leading to eventual secondary ischemic episodes due to vasoconstriction and to the formation of new thrombi, but also to BBB…”
BackgroundGoldstein, B. I., Collinger, K. A., Lotrich, F., Marsland, A. L., Gill, M.-K., Axelson, D. A., & Birmaher, B. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0009 · Cited by 97
“These exclusion criteria were determined based on known associations with PIMs (Lovell et al. 2000; Imhof et al. 2001; Pacifici et al. 2003; Joe et al. 2007; Wright et al. 2010).”
MethodGiménez, M., Gilabert, R., Monteagudo, J., Alonso, A., Casamitjana, R., Paré, C., & Conget, I. (2011) · Diabetes Care · doi:10.2337/dc10-1371 · Cited by 94
“Recurrent hypoglycemic episodes may provoke changes in hemostatic factors and viscosity, which may reduce perfusion in diabetic microangiopathy (11,12).”
BackgroundProinflammatory effects of hypoglycemia in humans with or without diabetes
Ratter, J. M., Rooijackers, H. M. M., Tack, C. J., Hijmans, A. G. M., Netea, M. G., de Galan, B. E., & Stienstra, R. (2017) · Diabetes · doi:10.2337/db16-1091 · Cited by 94
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
Hanefeld, M., Duetting, E., & Bramlage, P. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-135 · Cited by 93
“So far, it has been suggested that acute or recurrent hypoglycaemic episodes could induce thrombosis and inflammation [12], abnormal cardiac repolarization, arrhythmia and atrial fibrillation [13], endothelial injury [14], myocardial ischemia and cerebral damage [15], and preclinical atherosclerosis”
BackgroundInfluentialBedenis, R., Price, A. H., Robertson, C. M., Morling, J. R., Frier, B. M., Strachan, M. W. J., & Price, J. F. (2014) · Diabetes Care · doi:10.2337/dc14-0908 · Cited by 87
Self-citationEffect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans
Iqbal, A., Prince, L. R., Novodvorský, P., Bernjak, A., Thomas, M. R., Birch, L., Lambert, D., Kay, L. J., Wright, F., Macdonald, I. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01168 · Cited by 97
“An older investigation into the effect of hypoglycemia on monocyte-platelet interactions in type 1 diabetes and healthy controls also suggested a trend toward increased MPA formation, but these data were not conclusive, with little difference between euglycemic and hypoglycemic conditions (42).”
Self-citationRate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings
Pleus, S., Schoemaker, M., Morgenstern, K., Schmelzeisen-Redeker, G., Haug, C., Link, M., Zschornack, E., & Freckmann, G. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815578716 · Cited by 83
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes
Gruden, G., Barutta, F., Chaturvedi, N., Schalkwijk, C., Stehouwer, C. D., Witte, D. R., Fuller, J. H., Cavallo Perin, P., & Bruno, G. (2012) · Diabetes Care · doi:10.2337/dc11-1531 · Cited by 76
Proinflammatory and Prothrombotic Effects of Hypoglycemia
Dandona, P., Chaudhuri, A., & Dhindsa, S. (2010) · Diabetes Care · doi:10.2337/dc10-0503 · Cited by 76
The clinical impact of inpatient hypoglycemia
Brutsaert, E. F., Carey, M., & Zonszein, J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.002 · Cited by 78
“Hypoglycemia in healthy controls and subjects with T1DM causes an increase in plateletmonocyte adhesion and markers of platelet activation (P-selectin) and inflammation (monocyte CD-40, IL-6 and hsCRP) (Wright et al., 2010).”
BackgroundPozza, R. D., Beyerlein, A., Thilmany, C., Weißenbacher, C., Netz, H., Schmidt, H., & Bechtold, S. M. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-53 · Cited by 73
Prolonged prothrombotic effects of antecedent hypoglycemia in individuals with type 2 diabetes
Chow, E., Iqbal, A., Walkinshaw, E., Phoenix, F., Macdonald, I. A., Storey, R. F., Ajjan, R., & Heller, S. R. (2018) · Diabetes Care · doi:10.2337/dc18-0050 · Cited by 63
Self-citationLu, C.-L., Shen, H.-N., Hu, S. C., Wang, J.-D., & Li, C.-Y. (2016) · Diabetes Care · doi:10.2337/dc15-2418 · Cited by 66
Bajaj, H. S., Venn, K., Ye, C., Patrick, A., Kalra, S., Khandwala, H., Aslam, N., Twum-Barima, D., & Aronson, R. (2017) · Diabetes Care · doi:10.2337/dc16-1582 · Cited by 65
Lumbosacral radiculoplexus neuropathy
Ng, P. S., Dyck, P. J. B., Laughlin, R. S., Thapa, P. B., Pinto, M. V., & Dyck, P. J. B. (2019) · Neurology · doi:10.1212/wnl.0000000000007020 · Cited by 61
Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes
Christou, M., Christou, P. A., Kyriakopoulos, C., Christou, G. A., & Tigas, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119357 · Cited by 71
“It has been shown that a longer duration of hypoglycemia results in a greater increase in proinflammatory markers even if glucose levels are higher [46,47].”
BackgroundPeña, A. S., Couper, J., Harrington, J., Gent, R. J., Fairchild, J. M., Tham, E., & Baghurst, P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0229 · Cited by 62
“Children with T1D have higher glucose variability and a higher number of hypoglycemic episodes compared with adults with type 1 or type 2 diabetes.19,20 After a short duration of T1D they have vascular endothelial and smooth muscle dysfunction as measured by FMD and glyceryl trinitrate– induced dilatation (GTN), respe…”
BackgroundInfluentialWakasugi, S., Mita, T., Katakami, N., Okada, Y., Yoshii, H., Osonoi, T., Kuribayashi, N., Taneda, Y., Kojima, Y., Gosho, M., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01194-2 · Cited by 62
“Similarly, some recent studies have demonstrated that the acute effects of hypoglycemia include inflammation and endothelial injury in patients with type 1 diabetes [35, 36].”
ResultIqbal, A., & Heller, S. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.004 · Cited by 64
Mitochondrial regulation of diabetic vascular disease: an emerging opportunity
Widlansky, M. E., & Hill, R. B. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.015 · Cited by 66
Fadini, G. P., de Kreutzenberg, S. V., Mariano, V., Boscaro, E., Bertolini, F., Mancuso, P., Quarna, J., Marescotti, M. C., Agostini, C., Tiengo, A., et al. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01396.x · Cited by 55
“Indeed, adiposity is an important determinant of future coronary events [14], while hypoglycaemia has pro-inflammatory and prothrombotic effects [12,13] and can even precipitate acute coronary syndromes [28].”
BackgroundKim, Y.-G., Park, D. G., Moon, S. Y., Jeon, J. Y., Kim, H. J., Kim, D. J., Lee, K.-W., & Han, S. J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0260 · Cited by 50
Exposure to hypoglycemia and risk of stroke
Smith, L., Chakraborty, D., Bhattacharya, P., Sarmah, D., Koch, S., & Dave, K. R. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13872 · Cited by 60
Clayton, D., Woo, V. C., & Yale, J. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.022 · Cited by 75
GLP-1 Receptor: A New Target for Sepsis
Yang, F., Zeng, F., Luo, X., Lei, Y., Li, J., Lu, S., Huang, X., Lan, Y., & Liu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.706908 · Cited by 48
“Acute hypoglycemia increases oxidative stress, platelet aggregation, production of pro-inflammatory cytokines, and the expression of vascular adhesion molecules (Gogitidze Joy et al., 2010; Wright et al., 2010).”
BackgroundMelmer, A., & Laimer, M. W. (2016) · Endocrine development · doi:10.1159/000439364 · Cited by 58
Fährmann, E. R., Adkins, L., Loader, C. J., Han, H., Rice, K. M., Denvir, J., & Driscoll, H. K. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.10.007 · Cited by 47
Hsu, J., Yang, Y., Chuang, S.-L., Yu, C., & Lin, L. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01341-3 · Cited by 51
Avogaro, A., Dardano, A., de Kreutzenberg, S. V., & Prato, S. D. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12319 · Cited by 49
“Finally, as documented by an increase in both CD40 and high-sensitivity C-reactive protein, an inflammatory response accompanies hypoglycaemia [25].”
BackgroundUnderstanding the impact of hypoglycemia on the cardiovascular system
Davis, I., Ahmadizadeh, I., Randell, J., Younk, L. M., & Davis, S. N. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1275960 · Cited by 50
Yao, M., Hao, Y., Wang, T., Xie, M., Li, H., Feng, J., Feng, L., & Ma, D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1149671 · Cited by 55
The Impact of Hypoglycemia on the Cardiovascular System: Physiology and Pathophysiology
Yang, S., Park, K., & Zhou, Y.-J. (2015) · Angiology · doi:10.1177/0003319715623400 · Cited by 55
Han, E., Han, K.-D., Lee, B.-W., Kang, E. S., Cha, B.-S., Ko, S.-H., & Lee, Y.-H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab860 · Cited by 41
“Third, endothelial dysfunction and vascular injury evoked by hypoglycemia contribute to cognitive decline (28, 29).”
BackgroundBuse, J. B., Kudva, Y. C., Battelino, T., Davis, S. N., Shin, J., & Welsh, J. B. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0294 · Cited by 41
McNeilly, A. D., Gallagher, J. R., Dinkova‐Kostova, A. T., Hayes, J. D., Sharkey, J., Ashford, M. L. J., & McCrimmon, R. J. (2016) · Diabetes · doi:10.2337/db15-1653 · Cited by 41
Significance of Glycemic Variability in Diabetes Mellitus
Kusunoki, Y., Konishi, K., Tsunoda, T., & Koyama, H. (2022) · Internal Medicine · doi:10.2169/internalmedicine.8424-21 · Cited by 40
“Therefore, CGM may be considered for GV suppression in both T 1DM and T2DM.”
BackgroundInfluentialGauer, J. S., Ajjan, R., & Ariëns, R. A. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027071 · Cited by 50
Joy, N. G., Perkins, J. M., Mikeladze, M., Younk, L., Tate, D. B., & Davis, S. N. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.030 · Cited by 33
Freckmann, G., Pleus, S., Link, M., Baumstark, A., Schmid, C., Högel, J., & Haug, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0043 · Cited by 37
Şerban, R. C., & Scridon, A. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.018 · Cited by 39
Fagher, K., & Löndahl, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2860-x · Cited by 37
Al‐Qaissi, A., Papageorgiou, M., Deshmukh, H., Madden, L. A., Rigby, A. S., Kilpatrick, E. S., Atkin, S. L., & Sathyapalan, T. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13548 · Cited by 38
“Few experimental studies have explored the effects of acute hypoglycaemia on MPs expressed by endothelial or other cells (ie, platelets, mononuclear cells) in humans.(12,14) In individuals with and without type 1 diabetes, Joy et al(14) demonstrated an increase in VCAM (CD106), ICAM (CD54), E-selectin (CD62-E), P-sele…”
BackgroundPlatelet function following induced hypoglycaemia in type 2 diabetes
Kahal, H., Aburima, A. A., Spurgeon, B. E. J., Wraith, K. S., Rigby, A. S., Sathyapalan, T., Kilpatrick, E. S., Naseem, K. M., & Atkin, S. L. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.04.004 · Cited by 34
Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease
Rezende, P. C., Everett, B. M., Brooks, M. M., Vlachos, H., Orchard, T. J., Frye, R. L., Bhatt, D. L., & Hlatky, M. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.067 · Cited by 33
Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles
Tanner, M. J., Wang, J., Ying, R., Suboc, T. M. B., Malik, M. A., Couillard, A. B., Branum, A., Puppala, V. K., & Widlansky, M. E. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2016 · Cited by 34
“Exciting recent data show that exposure to a clinically relevant hypoglycemic condition, experimentally defined as a state of low-glucose (LG) concentration, results in vascular endothelial dysfunction, manifested by both vascular inflammation and impairment of nitric oxide (NO)-mediated, endothelium-dependent dilatio…”
BackgroundKlingbeil, K. D., Koch, S., & Dave, K. R. (2017) · International Journal of Stroke · doi:10.1177/1747493017743797 · Cited by 33
Ajjan, R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16098 · Cited by 40
Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
Iqbal, A., Novodvorský, P., & Heller, S. R. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.3 · Cited by 45
“Hypoglycaemia has been shown to be pro-thrombotic by causing both platelet aggregation and activation [79,80] which is likely to be mediated by the catecholamine response to hypoglycaemia [80].”
BackgroundShah, F. A., Mahmud, H., Gallego‐Martin, T., Jurczak, M. J., O'Donnell, C. P., & McVerry, B. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00296 · Cited by 33
Hypoglycemia as a Driver of Cardiovascular Risk in Diabetes
Moheet, A. A., & Seaquist, E. R. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0351-7 · Cited by 33
Intensive glucose control and hypoglycaemia: a new cardiovascular risk factor?
Rana, O. A., Byrne, C. D., & Greaves, K. (2013) · Heart · doi:10.1136/heartjnl-2013-303871 · Cited by 34
Stress, hypoglycemia, and the autonomic nervous system
Haas, A., Borsook, D., Adler, G., & Freeman, R. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.102983 · Cited by 30
Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies
Kaur, J., & Seaquist, E. R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00762-8 · Cited by 38
Gajos, G., Konieczyńska, M., Zalewski, J., & Undas, A. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0207-2 · Cited by 27
Baroreflex sensitivity impairment during hypoglycemia: implications for cardiovascular control
Rao, A. D., Bonyhay, I., Dankwa, J., Baimas-George, M., Kneen, L., Ballatori, S., Freeman, R., & Adler, G. K. (2016) · Diabetes · doi:10.2337/db15-0871 · Cited by 25
Kilpatrick, E. S., Rigby, A. S., Atkin, S. L., & Frier, B. M. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03612.x · Cited by 25
Self-citationChiang, H.-H., Tseng, F., Wang, C., Chen, C., Chen, Y., See, T.-T., & Chen, H.-F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109501 · Cited by 28
“Possible mechanisms by which hypoglycemia might cause cardiovascular disease or death include sympathoadrenal activation, abnormal cardiac repolarization, increased thrombogenesis, vasoconstriction, and the release of inflammatory mediators and cytokines [39].”
BackgroundJoy, N. G., Mikeladze, M., Younk, L. M., Tate, D. B., & Davis, S. N. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.001 · Cited by 24
“There are only a few studies reporting the effects of hypoglycemia on fibrinolytic/coagulation mechanisms in healthy and type 1 diabetes individuals [28, 29, 36], but no data reporting these effects during hypoglycemia in type 2 diabetic humans.”
BackgroundBaumstark, A., Jendrike, N., Pleus, S., Haug, C., & Freckmann, G. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0408 · Cited by 22
Kieć‐Wilk, B., Matejko, B., Raźny, U., Stankiewicz, M. A., SKUPIEN, J. K., Klupa, T., & Malecki, M. T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.002 · Cited by 22
Update on strategies limiting iatrogenic hypoglycemia
Bonaventura, A., Montecucco, F., & Dallegri, F. (2015) · Endocrine Connections · doi:10.1530/ec-15-0044 · Cited by 26
Yang, C., Liao, W.-I., Tang, Z.-C., Wang, J., Lee, C., Chang, W., Hsu, C.-W., Tang, S.-E., & Tsai, S. (2017) · International Journal of COPD · doi:10.2147/copd.s131232 · Cited by 23
Pathomorphological effects of Alloxan induced acute hypoglycaemia in rabbits
Mir, M. S., Darzi, M. M., Khan, H. M., Kamil, S. A., Sofi, A. H., & Wani, S. A. (2013) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2013.03.007 · Cited by 26
“Upregulation and release of vasoactive substances has been suggested as a putative mechanism for hypoglycaemic vascular injury.(4) Hypoglycaemia has been incriminated as one of the important factors for pulmonary hypertension in human neonates.”
BackgroundHe, A., Guo, Y., Xu, Z., Yan, J., Xie, L., Li, Y., Lv, D., & Luo, M. (2022) · Microvascular Research · doi:10.1016/j.mvr.2022.104468 · Cited by 22
The effect of insulin-induced hypoglycemia on inflammatory markers: a systematic review
Drummond, J. B., Barbosa, I. G., Dantzer, R., & Teixeira, A. L. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.003 · Cited by 16
Aberer, F., Pferschy, P. N., Tripolt, N. J., Sourij, C., Obermayer, A. M., Prüller, F., Novak, E., Reitbauer, P., Kojzar, H., Prietl, B., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13889 · Cited by 19
“These results are in line with data shown previously which demonstrated similar vWF properties in people with type 1 diabetes but not in healthy individuals.(16) Zakai et al(30) recently suggested elevated factor VIII levels to be predictive of coronary heart disease and stroke, and this risk was more pronounced in pa…”
ResultPiarulli, F., Sartore, G., Sechi, A., Basso, D., Fogar, P., Greco, E., Ragazzi, E., & Lapolla, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9185272 · Cited by 18
Pathophysiology and management of hypoglycemia in diabetes
RANGEL, E. S., Deajon-Jackson, J. D., & Hwang, J. J. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14904 · Cited by 21
Hypoglycaemia, thrombosis and vascular events in diabetes
King, R., & Ajjan, R. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1215916 · Cited by 17
“[18,19] and increased oxidative stress [33].”
ResultFadini, G. P., Albiero, M., de Kreutzenberg, S. V., & Avogaro, A. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0247-1 · Cited by 16
Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
Katsiki, N., Kotsa, K., Stoian, A. P., & Mikhailidis, D. P. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200909142658 · Cited by 16
Kim, W. J., Noh, J. H., Han, K., & Park, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201535 · Cited by 17
How to Best Manage Glycemia and Non-Glycemia During the Time of Acute Myocardial Infarction
Hirsch, I. B., & O’Brien, K. D. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0095 · Cited by 19
“Perhaps this is not surprising as we learn about the impact of hypoglycemia on inflammatory activation.(30) This concern may even be more relevant for a patient with AMI because of the negative impact of hypoglycemia on ischemia(31) and arrhythmia.”
BackgroundChoi, S.-Y., & Ko, S. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.327 · Cited by 18
Grieco, D., Palamà, Z., Borrelli, A., Ruvo, E. D., Sciarra, L., Scarà, A., Goanta, E. V., Calabrese, V., Pozzilli, P., Sciascio, G. D., et al. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117752492 · Cited by 16
“7 NS NYHA classification – no heart failure, n (%) 28 (91) 26 (86) NS NYHA classification I, n (%) 2 (6) 2 (10)s NS NYHA classification II, n (%) 1 (3) 1 (4) NS Medical history – no cardiovascular disease, n (%) 29 (95) 32 (80) NS Previous stroke, n (%) 1 (3) 1 (4) NS Previous myocardial infarction, n (%) 3 (5) 0 (6)…”
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
Alicic, R. Z., Neumiller, J. J., & Tuttle, K. R. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01036-y · Cited by 22
Moser, O., Rafferty, J., Eckstein, M. L., Aziz, F., Bain, S. C., Bergenstal, R. M., Sourij, H., & Thomas, R. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15102 · Cited by 17
Luk, A. O. Y., Ho, T. S. T., Lau, E. S. H., Ko, G. T. C., Ozaki, R., Tsang, C.-C., Kong, A. P. S., Ronald, C. W., So, W., Chow, F. C. C., et al. (2016) · Medicine · doi:10.1097/md.0000000000005183 · Cited by 18
Tseng, J., Chen, H., Huang, K., Hsu, S.-P., & Chen, C. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13951 · Cited by 13
“Furthermore, both hyperglycaemia and hypoglycaemic episodes may trigger an inflammatory reaction and procoagulant response.(36,37) Such glucose fluctuation activates oxidative stress,(38) which leads to cellular damage.”
BackgroundWinhofer, Y., Krššák, M., Wolf, P. S., Anderwald, C. H., Geroldinger, A., Heinze, G., Baumgartner-Parzer, S. M., Marculescu, R., Stulnig, T. M., Wolzt, M., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00371.2014 · Cited by 14
Metadata
- Authors
- Wright, R. J., Newby, D. E., Stirling, D., Ludlam, C. A., Macdonald, I. A., & Frier, B. M.
- Affiliations
- Edinburgh Royal Infirmary (GB)
- University of Edinburgh (GB)
- University of Nottingham (GB)
- Corresponding author
- Frier, Brian M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-07-01
- Volume
- 33
- Issue
- 7
- Pages
- 1591-1597
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890364
- OpenAlex
- W2144610870
- Cited by
- 208
- References
- 27
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 11 · 2023: 13 · 2022: 13 · 2021: 14 · 2020: 12 · 2019: 7 · 2018: 17 · 2017: 10 · 2016: 18 · 2015: 21 · 2014: 18 · 2013: 10 · 2012: 11
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Diabetes UK
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- insulin-induced hypoglycemia, inflammation, endothelial dysfunction, platelet activation, type 1 diabetes, CD40 expression, soluble CD40 ligand, C-reactive protein, P-selectin, von Willebrand factor, tissue plasminogen activator, thrombosis
- MeSH terms
- Adult, Blood Glucose, Blood Platelets, C-Reactive Protein, Diabetes Mellitus, Type 1, Diabetic Angiopathies, Endothelium, Vascular, Female, Flow Cytometry, Humans, Hypoglycemia, Hypoglycemic Agents, Inflammation, Insulin, Male, Monocytes, Tissue Plasminogen Activator, Vasculitis, von Willebrand Factor, Biomarkers, Platelet Activation, Interleukin-6, P-Selectin, CD40 Antigens, CD40 Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.